RecallRadar

FDA Drug recall D-0391-2015

1% LIDOCAINE HCl Injection, USP, 10 mg/mL, 30 mL Single-dose, Preservative-Free glass vial (Twenty-five (25) units per box/fifty (50) units…

On 2015-02-25 the FDA classified a Class I recall of 1% LIDOCAINE HCl Injection, USP, 10 mg/mL, 30 mL Single-dose, Preservative-Free glass vial (Twenty-five (25) units per box/fifty (50) units… by Hospira, citing presence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0391-2015
ClassificationClass I
Statusterminated
Initiated2014-10-16
Published2015-02-25
Last updated2026-09-13 11:51 UTC
CompanyHospira
DistributionUS

Product

1% LIDOCAINE HCl Injection, USP, 10 mg/mL, 30 mL Single-dose, Preservative-Free glass vial (Twenty-five (25) units per box/fifty (50) units per case, NDC 0409-4279-02, Hospira, Inc., Lake Forest, IL 60045

Reason

Presence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.

Identifiers

ndc0409-4713-12
ndc0409-4713-26
ndc0409-4713-02
ndc0409-4713-72
ndc0409-4713-62
ndc0409-4713-75
ndc0409-4713-65
ndc0409-4713-42
ndc0409-4713-25
ndc0409-4713-32
ndc0409-4278-16
ndc0409-4278-01
ndc0409-4279-16
ndc0409-4279-02
ndc0409-4776-10
ndc0409-4776-01
ndc0409-4282-11
ndc0409-4282-25
ndc0409-4282-01
ndc0409-4282-12
ndc0409-4282-02
ndc0409-4277-16
ndc0409-4277-01
ndc0409-4277-17
ndc0409-4277-02
ndc0409-4276-16
ndc0409-4276-01
ndc0409-4276-17
ndc0409-4276-02
ndc0409-4275-16
ndc0409-4275-01
code_infoLot# 40-316-DK, Exp 01APR2016

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0391-2015%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.